OPENPediatrics

Results of Hypertonic Saline or Mannitol Clinical Trial for Treatment of Children with Severe TBI

Apr 25, 2022
Dr. Patrick Kochanek, a Distinguished Professor of Critical Care Medicine and director at the University of Pittsburgh, discusses groundbreaking findings from the ADAPT trial. He shares key insights on comparing hypertonic saline and mannitol in treating severe pediatric traumatic brain injury. Unexpected results regarding intracranial pressure measurement come to light, prompting a reevaluation of current treatment methodologies. Dr. Kochanek also highlights the challenges faced in pediatric trials and the potential impact on future clinical practices.
Ask episode
Chapters
Transcript
Episode notes